Ben Jenkins
ben-j-jenkins.bsky.social
Ben Jenkins
@ben-j-jenkins.bsky.social
Imiwnolegydd Cymraeg 🏴󠁧󠁢󠁷󠁬󠁳󠁿 • Post Doc @ Swansea University in Nick Jones' group • Interested in #immunometabolism and disease, currently focussing on T cells
Pinned
Pleased to be able to share our latest work on mitochondrial ABHD11 and its role in regulating T-cell function.

Really cool to get to co-author this one with my sister as well.

Massive thank you as always to everyone who's been involved with the project.
Grateful for the opportunity to present our work at #BSI25. Thanks to everyone who took the time to come and have a chat about our poster on the role of mitochondrial ABHD11 in controlling T-cell responses (P-373). A great week of immunology as always!
December 4, 2025 at 7:09 PM
Reposted by Ben Jenkins
Mitochondrial ABHD11 inhibition drives sterol metabolism to modulate T-cell effector function @natcomms.nature.com @nickjonesimmuno.bsky.social
www.nature.com/articles/s41...
November 3, 2025 at 11:18 PM
Pleased to be able to share our latest work on mitochondrial ABHD11 and its role in regulating T-cell function.

Really cool to get to co-author this one with my sister as well.

Massive thank you as always to everyone who's been involved with the project.
November 3, 2025 at 6:35 PM
Reposted by Ben Jenkins
Ecstatic to share out latest research looking at the role of mitochondrial ABHD11 in controlling T-cell responses. We think this may be a viable target for autoimmunity. Please do give it a read, we would love to hear your thoughts.

www.nature.com/articles/s41...
Mitochondrial ABHD11 inhibition drives sterol metabolism to modulate T-cell effector function - Nature Communications
α/β-hydrolase domain-containing protein 11 (ABHD11) is a mitochondrial hydrolase, and its expression in CD4 + T-cells has been linked to remission status in rheumatoid arthritis. Here the authors repo...
www.nature.com
November 3, 2025 at 10:20 AM
Reposted by Ben Jenkins
Really pleased to share the labs first publication in paediatric T-cell leukaemia. We find that the type 2 diabetes drug canagliflozin possesses anti-leukaemic effects that can be enhanced via dietary restriction of serine.

www.sciencedirect.com/science/arti...
Canagliflozin synergises with serine restriction mediating anti-leukaemic effects in T-cell acute lymphoblastic leukaemia
T-cell acute lymphoblastic leukaemia (T-ALL) is a haematological malignancy commonly driven by NOTCH1 activating mutations. A concomitant feature asso…
www.sciencedirect.com
October 21, 2025 at 9:37 AM
Reposted by Ben Jenkins
Secondly, PhD student Emma Lucas and myself contributed towards how metabolism shapes relapsed/refractory T-cell acute lymphoblastic leukaemia, led by João Barata and colleagues from the T-ALL special interest group

www.nature.com/articles/s41...
Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemia - Leukemia
Leukemia - Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemia
www.nature.com
August 14, 2025 at 7:26 PM
Reposted by Ben Jenkins
Really pleased to share two review articles the lab has been involved in lately 👇🏻
Thanks for the involvement!
August 14, 2025 at 7:26 PM
Reposted by Ben Jenkins
Delighted to share our new review in @cp-trendsendomet.bsky.social on Repurposing metabolic drugs (GLP-1s & SGLT2s) as anti-inflammatory agents! Thanks to @nickjonesimmuno.bsky.social for this joint effort
doi.org/10.1016/j.te...
August 13, 2025 at 9:21 PM
Reposted by Ben Jenkins
First preprint from the lab! Massive effort from @ben-j-jenkins.bsky.social and Yasmin. Thanks always to great collaborators and co-leads James and Emma. Any feedback greatly appreciated:

www.biorxiv.org/content/10.1...
ABHD11 inhibition drives sterol metabolism to modulate T cell effector function and alleviate autoimmunity
Chronic inflammation in autoimmunity is driven by T cell hyperactivation. This unregulated response to self is fuelled by heightened metabolic programmes, which offers a promising new direction to unc...
www.biorxiv.org
March 20, 2025 at 8:46 AM